Literature DB >> 1551946

Cultured human granulosa cells as a model for corpus luteum function: relative roles of gonadotrophin and low density lipoprotein studied under defined culture conditions.

M C Richardson1, D W Davies, R H Watson, M L Dunsford, C B Inman, G M Masson.   

Abstract

In primates, corpus luteum development involves both gonadotrophin stimulation and exposure to low density lipoprotein (LDL) delivered through vascularization of the granulosa cell-derived layer. These regulatory influences were modelled in vitro using granulosa cells obtained during in-vitro fertilization (IVF) cycles controlled with gonadotrophin releasing hormone (GnRH) analogue, human menopausal gonadotrophin (HMG) and human chorionic gonadotrophin (HCG). Granulosa cells were cultured in defined medium on extracellular matrix. Without gonadotrophin or LDL in the medium, progesterone production declined progressively. With LDL alone, there was a short-lived elevation of progesterone output which subsequently declined. Culture with HCG alone resulted in a relatively unchanged rate of steroid production over 5 days despite morphological development. This contrasted with a marked and sustained increase in progesterone output over the same time when granulosa cells were cultured with combined HCG/LDL. Cultures were challenged with combined HCG/LDL on day 5. Where initial incubation included HCG, the challenge resulted in a recovery of progesterone output to values comparable to those of granulosa cells exposed to continuous HCG/LDL. Initial incubation without gonadotrophin led to a reduced response. Results suggest that LDL delivery to granulosa cells of the early corpus luteum causes a short-lived period of progesterone production. Sustained luteinization of granulosa cells and maintenance of gonadotrophin responsiveness requires continued exposure to gonadotrophin in the luteal phase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551946     DOI: 10.1093/oxfordjournals.humrep.a137543

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Gonadotropin- and lipoprotein-supported progesterone production by primate luteal cell types in culture.

Authors:  S L Sanders; R L Stouffer
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

2.  Rearrangement of extracellular matrix during cluster formation by human luteinising granulosa cells in culture.

Authors:  M C Richardson; C Slack; I J Stewart
Journal:  J Anat       Date:  2000-02       Impact factor: 2.610

Review 3.  Cholesterol as a potential target for castration-resistant prostate cancer.

Authors:  Alexis L Twiddy; Carlos G Leon; Kishor M Wasan
Journal:  Pharm Res       Date:  2010-08-04       Impact factor: 4.200

4.  The optimum time for exogenous human chorionic gonadotropin to rescue the corpus luteum.

Authors:  P Y Tay; E A Lenton
Journal:  J Assist Reprod Genet       Date:  1999-10       Impact factor: 3.412

5.  Hormone release from cultured luteinized-granulosa cells mimics differences seen in vivo in patients undergoing IVF-ET.

Authors:  S D Prien; M S Canez; R H Messer
Journal:  J Assist Reprod Genet       Date:  1995-03       Impact factor: 3.412

6.  Disparities in childhood overweight and obesity by income in the United States: an epidemiological examination using three nationally representative datasets.

Authors:  Robert G Weaver; Keith Brazendale; Ethan Hunt; Mark A Sarzynski; Michael W Beets; Kellee White
Journal:  Int J Obes (Lond)       Date:  2019-02-04       Impact factor: 5.095

7.  Phenotypes of the ovarian follicular basal lamina predict developmental competence of oocytes.

Authors:  Helen F Irving-Rodgers; Stephanie Morris; Rachael A Collett; Teija T Peura; Margaret Davy; Jeremy G Thompson; Helen D Mason; Raymond J Rodgers
Journal:  Hum Reprod       Date:  2008-12-18       Impact factor: 6.918

Review 8.  Cells with stem cell characteristics in somatic compartments of the ovary.

Authors:  Katarzyna Kossowska-Tomaszczuk; Christian De Geyter
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.